Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLB for pain control after endoscopic prostatectomy
NCT03600129Completed
- Sponsor
- Centrum Medyczne Kształcenia Podyplomowego
- Start
- Jul 2018
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Centrum Medyczne Kształcenia Podyplomowego. Primary endpoint: Opioid consumption following prostatectomy at 24 hours. Started Jul 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03600129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03600129.